Citation Impact
Citing Papers
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother‐to‐infant transmission of hepatitis B virus
2015
Management of hepatitis B
2007
The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
2012
SCHEMA Recombination of a Fungal Cellulase Uncovers a Single Mutation That Contributes Markedly to Stability
2009 StandoutNobel
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context
2006 StandoutNobel
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
2010
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation
2005
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
HBV and HIV Coinfection and Liver Transplant
2010
Virologic response and resistance to adefovir in patients with chronic hepatitis B
2005
Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency 1 1Edited by J. A. Wells
1999
Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus Infection
2004
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution
1997
A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-Refractory Chronic Hepatitis B Patients
2005
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
2016
Lateral gene transfer and the nature of bacterial innovation
2000 StandoutNature
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
New insight in the pathobiology of hepatitis B virus infection
2012
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability
2015
Antiviral drug-resistant HBV
2007
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
2014
Hepatitis B virus infection
2009 Standout
Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers
2013
Hepatitis B cure: From discovery to regulatory approval
2017
The role of quantitative hepatitis B surface antigen revisited
2016
Entecavir resistance is rare in nucleoside naïve patients with hepatitis B
2006
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
2004 Standout
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
2016
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women
2012
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1
2005
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Antibodies in proteomics I: generating antibodies
2003
Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants
2012
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
2016
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients
2006
Efficient Sampling of SCHEMA Chimera Families to Identify Useful Sequence Elements
2013 StandoutNobel
Overview of hepatitis B viral replication and genetic variability
2016
Viral hepatitis B
2003
[28] Methods for generating multivalent and bispecific antibody fragments
2000
Molecular Virology of Hepatitis B Virus
2004
Management of treatment failure in chronic hepatitis B
2012
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in VL to VH orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers
2000
Chronic hepatitis B: Update 2009 #
2009 Standout
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Increased risk of adefovir resistance in patients with lamivudine‐resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy†
2006
Optimal management of hepatitis B virus infection – EASL Special Conference
2015
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
2008
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus
2014
Recombinant antibody fragments
1998
Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
2011
Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals after the Initiation of HBV‐Active Antiretroviral Therapy
2009
Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype
2012
Helicobacter pyloriInfection
2002 Standout
Hepatitis B virus variants
2009
Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers
2011
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
2007
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
2006
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound†
2008
The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus
1998
Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study
2014
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Adaptive immunity in HBV infection
2016
Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites
2011
Infection in Solid-Organ Transplant Recipients
2007 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
2005
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B
2005
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels
2012
ISfinder: the reference centre for bacterial insertion sequences
2005 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis
2010
VFDB: a reference database for bacterial virulence factors
2004 Standout
Performance Evaluation of New Automated Hepatitis B Viral Markers in the Clinical Laboratory
2012
NAFLD: A multisystem disease
2015 Standout
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Chronic Hepatitis B: Current Testing Strategies
2006
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
2000 StandoutScience
Genome‐free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy
2014
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
AASLD guidelines for treatment of chronic hepatitis B
2015
Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance
2013
Prevention of materno‐foetal transmission of hepatitis B in sub‐Saharan Africa: the evidence, current practice and future challenges
2014
Novel Cassette-Based Shuttle Vector System for Gram-Positive Bacteria
2004 StandoutNobel
New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
2013
cag , a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
1996 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Rigid, Specific, and Discrete Gold Nanoparticle/Antibody Conjugates
2006 StandoutNobel
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
2016
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus
2016
Functional Expression of a Fungal Laccase in Saccharomyces cerevisiae by Directed Evolution
2003 StandoutNobel
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
2015
Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection
2016
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
Anti‐viral therapy for prevention of perinatalHBV transmission: extending therapy beyond birth does not protect against post‐partum flare
2014
Inhibition of Hepatitis B Virus Polymerase by Entecavir
2007
Diverse and abundant antibiotic resistance genes in Chinese swine farms
2013 Standout
Molecularly Imprinted Polymers and Their Use in Biomimetic Sensors
2000 Standout
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
1998 StandoutScience
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
1998 Standout
Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine
2004
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir
2005
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Clinical course of 161 untreated and tenofovir‐treated chronic hepatitisB pregnant patients in a low hepatitisB virus endemic region
2015
Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation
2016
Insertion Sequences
1998
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis
2015
Quality control in the endoplasmic reticulum
2003 Standout
Prevention of Hepatitis B Recurrence after Liver Transplantation
2005
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
2012
Management of patients with hepatitis B in special populations
2015
Works of Anna Ayres being referenced
HBV Genotyping and Analysis for Unique Mutations
2004
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
2006
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure
2003
Identification of a native Dichelobacter nodosus plasmid and implications for the evolution of the vap regions
1996
Molecular and clinical characteristics of hepatitis B virus in Korea
2010
Use of mutator cells as a means for increasing production levels of a recombinant antibody directed against Hepatitis B
1997
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing
2010
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
2003
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals
2007
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
2010
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV–HBV co-infected individuals
2003
Reduced Hepatitis B Virus (HBV)-Specific CD4+T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy
2005
The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro
2007
Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors
2006
Perinatal transmission of hepatitis B virus: an Australian experience
2009
Viral Adaptation to Host Immune Responses Occurs in Chronic Hepatitis B Virus (HBV) Infection, and Adaptation Is Greatest in HBV e Antigen-Negative Disease
2011